Case number 2017-2304
AbbVie Biotechnology, Ltd. v. US > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ABBVIE BIOTECHNOLOGY, LTD. v. US [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 28, 2020 | 134 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [675073] [17-2304, 17-2305, 17-2306, 17-2362, 17-2363] [JAB] [Entered: 02/28/2020 10:17 AM] (0) |
| Jan 7, 2020 | 133 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [661160] [17-2304, 17-2305, 17-2306, 17-2362, 17-2363] [MJL] [Entered: 01/07/2020 09:27 AM] (0) |
| Jan 6, 2020 | 132 | Submitted after ORAL ARGUMENT by Mr. Thomas Saunders for AbbVie Biotechnology, Ltd. and Mr. Nicholas Theodore Matich, IV for Iancu. Panel: Judge: Dyk , Judge: O'Malley , Judge: Chen. [660825] [JCP] [Entered: 01/06/2020 10:50 AM] (0) |
| Jan 2, 2020 | 131 | Entry of appearance for Kakoli Caprihan as of counsel for Intervenor Iancu. Service: 01/02/2020 by email, US mail. [659985] [17-2304] [Kakoli Caprihan] [Entered: 01/02/2020 08:59 AM] (0) |
| Nov 22, 2019 | 129 | Response to notice of oral argument from the Intervenors Iancu and US. [651686] [17-2304] [Nicholas Matich] [Entered: 11/22/2019 11:40 AM] (0) |
| Nov 22, 2019 | 130 | Response to notice of oral argument from the Appellant AbbVie Biotechnology, Ltd.. [651718] [17-2304] [Thomas Saunders] [Entered: 11/22/2019 12:22 PM] (0) |
| Nov 21, 2019 | 128 | NOTICE OF ORAL ARGUMENT. Panel: 2001B. Case scheduled January 6, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 12/16/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [651301] [JAB] [Entered: 11/21/2019 01:56 PM] (0) |
| Aug 26, 2019 | 125 | The following conflict dates submitted by Attorney Dennis Fan for Intervenor US have been accepted by the court: 11/04/2019, 11/05/2019, 11/06/2019, 11/07/2019, 11/08/2019. [630840] [JAB] [Entered: 08/26/2019 09:55 AM] (0) |
| Aug 26, 2019 | 126 | 6 paper copies of the Reply Brief [116] received from Appellant AbbVie Biotechnology, Ltd.. [630976] [CJF] [Entered: 08/26/2019 01:17 PM] (0) |
| Aug 26, 2019 | 127 | Notice from Intervenor Iancu regarding conflicts with oral argument. None. Service: 08/26/2019 by email. [631105] [17-2304] [Nicholas Matich] [Entered: 08/26/2019 05:00 PM] (0) |
| Aug 26, 2019 | 123 | Notice from Intervenor US regarding conflicts with oral argument. Service: 08/26/2019 by email, US mail. [630796] [17-2304] [Dennis Fan] [Entered: 08/26/2019 09:14 AM] (3) |
| Aug 26, 2019 | 124 | Notice from Appellant AbbVie Biotechnology, Ltd. regarding conflicts with oral argument. None. Service: 08/26/2019 by email, US mail. [630834] [17-2304] [Thomas Saunders] [Entered: 08/26/2019 09:53 AM] (0) |
| Aug 23, 2019 | 119 | **TEXT ONLY** ORDER filed. Pursuant to the notice filed by Intervenors Iancu and US on 08/22/2019 [118], Farheena Y. Rasheed is withdrawn as counsel for Iancu and US. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [630567] [JAL] [Entered: 08/23/2019 10:32 AM] (0) |
| Aug 23, 2019 | 120 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: party letter Docket No. [118], ERROR: The request to withdraw counsel from Intervenors Iancu and US [118] was not filed as a motion. CORRECTION: For future withdrawals, please file the document under the event Motions --> Motion. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [630568] [JAL] [Entered: 08/23/2019 10:33 AM] (0) |
| Aug 23, 2019 | 121 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [630572] [JAL] [Entered: 08/23/2019 10:35 AM] (0) |
| Aug 23, 2019 | 122 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [630573] [JAL] [Entered: 08/23/2019 10:36 AM] (1) |
| Aug 22, 2019 | 117 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Intervenors US and Iancu. Service: 08/22/2019 by email, US mail. [630176] [17-2304] [Dennis Fan] [Entered: 08/22/2019 11:06 AM] (3) |
| Aug 22, 2019 | 118 | Notice from Intervenors Iancu and US of Attorney Withdrawal. Service: 08/22/2019 by email. [630365] [17-2304] [Farheena Rasheed] [Entered: 08/22/2019 03:45 PM] (2) |
| Aug 20, 2019 | 116 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant AbbVie Biotechnology, Ltd. Number of Pages: 30. Service: 08/20/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [629576]--[Edited 08/23/2019 by JAL - Compliance review complete] [Thomas Saunders] [Entered: 08/20/2019 12:33 PM] (40) |
| Aug 2, 2019 | 114 | MOTION of Appellant AbbVie Biotechnology, Ltd. to extend the time to 08/20/2019 to file the Appellant's Replacement Reply Brief. [Consent: unopposed]. Service: 08/02/2019 by email, US mail. [625670] [17-2304] [Thomas Saunders] [Entered: 08/02/2019 12:21 PM] (6) |
| Aug 2, 2019 | 115 | **TEXT ONLY** ORDER granting motion to extend time to file brief [114] filed by Appellant AbbVie Biotechnology, Ltd. Appellant's reply brief is due 08/20/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [625680] [JAL] [Entered: 08/02/2019 12:48 PM] (0) |
| Aug 1, 2019 | 113 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Intervenors US and Iancu. Service: 08/01/2019 by email, US mail. [625118] [17-2304] [Dennis Fan] [Entered: 08/01/2019 09:28 AM] (3) |
| Jul 31, 2019 | 112 | 6 paper copies of the Corrected Intervenor Brief [111] received from Intervenors Iancu and US. [625058] [CJF] [Entered: 08/01/2019 06:57 AM] (0) |
| Jul 30, 2019 | 111 | MODIFIED ENTRY: CORRECTED INTERVENOR BRIEF FILED for Intervenors Iancu and US. Number of Pages: 60. Service: 07/30/2019 by email. [624402]--[Edited 07/31/2019 by JAL - Compliance review complete] [Dennis Fan] [Entered: 07/30/2019 09:39 AM] (72) |
| Jul 10, 2019 | 110 | Entry of appearance for Nicholas T. Matich IV as of counsel for Intervenor Iancu. Service: 07/10/2019 by email. [619988] [17-2304] [Nicholas Matich] [Entered: 07/10/2019 10:13 AM] (2) |
| Jun 25, 2019 | 109 | ORDER filed. The Director of the United States Patent and Trademark Office is added as an intervenor to Appeal Nos. 17-2362 and 17-2363. The revised official caption is reflected in the order. See order for further instructions.; - FOR CALENDAR. Service as of this date by the Clerk of Court. [616750] [17-2304, 17-2305, 17-2306, 17-2362, 17-2363] [JAL] [Entered: 06/25/2019 01:03 PM] (2) |
| Jun 20, 2019 | 106 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 06/20/2019 by email. [615751] [17-2304] [Meredith Schoenfeld] [Entered: 06/20/2019 11:28 AM] (3) |
| Jun 20, 2019 | 107 | Entry of appearance for Farheena Y. Rasheed as of counsel for Intervenor Iancu. Service: 06/20/2019 by email. [615754] [17-2304] [Farheena Rasheed] [Entered: 06/20/2019 11:33 AM] (2) |
| Jun 20, 2019 | 108 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor Iancu. Service: 06/20/2019 by email. [615755] [17-2304] [Thomas Krause] [Entered: 06/20/2019 11:38 AM] (2) |
| May 24, 2019 | 105 | ORDER filed. The May 21, 2019 order [104] is vacated. The motion to withdraw [103] is granted. The revised official caption is reflected in this order. The Director of the United States Patent and Trademark Office is directed to inform this court within 30 days of the date of filing of this order whether he will participate in Appeal Nos. 2017-2362, -2363. (see order for further details) A copy of this order shall be transmitted to the merits panel assigned to these appeals.; - FOR CALENDAR in 17-2304. Service: 05/24/2019 by clerk. [609496] [17-2304, 17-2362, 17-2363] [LMS] [Entered: 05/24/2019 09:26 AM] (3) |
| May 21, 2019 | 104 | ORDER filed. The motion to withdraw [103] is granted. The revised official caption is reflected in this order. The Director of the United States Patent and Trademark Office is directed to inform this court within 30 days of the date of filing of this order whether he will participate in Appeal Nos. 2017-2362, -2363. (see order for further details) A copy of this order shall be transmitted to the merits panel assigned to these appeals.; - FOR CALENDAR. Service: 05/21/2019 by clerk. [608585] [17-2304, 17-2362, 17-2363] Vacated pursuant to the court's order. See Doc No. [105] [LMS] [Entered: 05/21/2019 10:00 AM] (3) |
| May 15, 2019 | 103 | MOTION of Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. to withdraw party, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc., as a party to this appeal [Consent: unopposed]. Service: 05/15/2019 by email. [607390] [17-2304] [Eric Dittmann] [Entered: 05/15/2019 09:22 AM] (7) |
| May 1, 2019 | 102 | 6 paper copies of the Reply Brief [94] received from Appellant AbbVie Biotechnology, Ltd.. [604294] [CJF] [Entered: 05/01/2019 10:40 AM] (0) |
| Apr 30, 2019 | 97 | Notice from Intervenor US regarding conflicts with oral argument. Service: 04/30/2019 by email, US mail. [603930] [17-2304] [Dennis Fan] [Entered: 04/30/2019 10:47 AM] (3) |
| Apr 30, 2019 | 98 | Notice from Appellant AbbVie Biotechnology, Ltd. regarding conflicts with oral argument. None. Service: 04/30/2019 by email, US mail. [603953] [17-2304] [Thomas Saunders] [Entered: 04/30/2019 11:07 AM] (0) |
| Apr 30, 2019 | 99 | The following conflict dates submitted by Attorney Dennis Fan for Intervenor US have been accepted by the court: 07/10/2019, 07/11/2019, 07/12/2019. [604026] [JAB] [Entered: 04/30/2019 12:52 PM] (0) |
| Apr 30, 2019 | 100 | 6 paper copies of the Corrected Intervenor Brief [92] received from Intervenors Iancu and US. [604043] [CJF] [Entered: 04/30/2019 01:15 PM] (0) |
| Apr 30, 2019 | 101 | Notice from Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. regarding conflicts with oral argument. None. Service: 04/30/2019 by email, US mail. [604184] [17-2304] [Eric Dittmann] [Entered: 04/30/2019 04:59 PM] (0) |
| Apr 29, 2019 | 94 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant AbbVie Biotechnology, Ltd. Number of Pages: 30. Service: 04/29/2019 by email. [603726] --[Edited 04/29/2019 by JAL - Compliance review complete] This brief has been replaced. See Doc No.[116] [Thomas Saunders] [Entered: 04/29/2019 03:15 PM] (40) |
| Apr 29, 2019 | 95 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [603762] [JAL] [Entered: 04/29/2019 04:14 PM] (0) |
| Apr 29, 2019 | 96 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The notice of conflict with oral argument is due on or before 05/06/2019. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [603763] [JAL] [Entered: 04/29/2019 04:15 PM] (1) |
| Apr 22, 2019 | 93 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Intervenors US and Iancu. Service: 04/22/2019 by email, US mail. [602095] [17-2304] [Dennis Fan] [Entered: 04/22/2019 04:21 PM] (22) |
| Apr 17, 2019 | 91 | Notice of Correction to the Brief Doc No. [87], intervenor Brief Doc No. [87] for Intervenors US and Iancu. Service: 04/17/2019 by email, US mail. [601027] [17-2304] [Dennis Fan] [Entered: 04/17/2019 02:44 PM] (4) |
| Apr 17, 2019 | 92 | MODIFIED ENTRY: CORRECTED INTERVENOR BRIEF FILED for Intervenors Iancu and US. Number of Pages: 43. Service: 04/17/2019 by email. [601028]--[Edited 04/17/2019 by JAL - Compliance review complete] This brief has been corrected. See Doc No.[111] [Dennis Fan] [Entered: 04/17/2019 02:46 PM] (54) |
| Apr 16, 2019 | 88 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:intervenor Brief Docket No. [87], ERROR: Intervenors' brief [87] contained a signature that did not fully comply with the court's electronic signature requirements (the signature used "s/". CORRECTION: For future filings, pursuant to FCR 25(d), please use a siganture which contains the name of the filer whose log-in and password is used to submit the document preceded by "/s/". THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [600563] [JAL] [Entered: 04/16/2019 11:33 AM] (0) |
| Apr 16, 2019 | 89 | Entry of appearance for Scott R. McIntosh as of counsel for Intervenor US. Service: 04/16/2019 by email, US mail. [600602] [17-2304] [Scott McIntosh] [Entered: 04/16/2019 12:32 PM] (1) |
| Apr 16, 2019 | 90 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [89], ERROR: The entry of appearance for S. McIntosh [89] did not list all of the consolidated case numbers (17-2304, -2305, -2306, -2362, and -2363). CORRECTION: For future filings, please list all consolidated case numbers. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [600627] [JAL] [Entered: 04/16/2019 01:07 PM] (0) |
| Apr 15, 2019 | 87 | MODIFIED ENTRY: INTERVENOR BRIEF FILED for Intervenors Iancu and US. Number of Pages: 42. Service: 04/15/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. [600171] --[Edited 04/16/2019 by JAL - Compliance review complete] This brief has been corrected. See Doc No.[92] [Dennis Fan] [Entered: 04/15/2019 02:36 PM] (53) |
| Mar 19, 2019 | 84 | Notice to counsel for Intervenor Iancu: The record of this case indicates that the Entry of Appearance and Docketing Statement have not been filed. Pursuant to the court's 03/08/2019 order [83], please file these documents promptly. Service as of this date by the Clerk of Court. [593865] [JAL] [Entered: 03/19/2019 11:41 AM] (0) |
| Mar 19, 2019 | 85 | Entry of appearance for Meredith H. Schoenfeld as principal counsel for Intervenor Iancu. Service: 03/19/2019 by email. [594035] [17-2304] [Meredith Schoenfeld] [Entered: 03/19/2019 05:13 PM] (2) |
| Mar 19, 2019 | 86 | Docketing Statement for the Intervenor Iancu. Service: 03/19/2019 by email. [594037] [17-2304] [Meredith Schoenfeld] [Entered: 03/19/2019 05:19 PM] (3) |
| Mar 8, 2019 | 83 | ORDER filed. The Director is added as an intervenor to Appeal Nos. 17-2304, -2305, and -2306. The revised official caption for the consolidated appeals is reflected in the order. See order for further instructions. Service as of this date by the Clerk of Court. [591473] [17-2304, 17-2305, 17-2306, 17-2362, 17-2363]--[Edited 03/19/2019 by JAL to correct date of issuance on attached document] [JAL] [Entered: 03/08/2019 12:44 PM] (3) |
| Mar 4, 2019 | 82 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 03/04/2019 by email. [590129] [17-2304] [Farheena Rasheed] [Entered: 03/04/2019 03:32 PM] (3) |
| Jan 31, 2019 | 81 | ORDER filed. The motion to withdraw [80] is granted. The revised official caption and short caption are reflected in this order. The Director of the United States Patent and Trademark Office is directed to inform this court within 30 days of the date of this order whether he will participate in these appeals. A copy of this order shall be transmitted to the merits panel assigned to these appeals. (Please see order for further details.); - FOR CALENDAR. Service: 01/31/2019 by clerk. [582376] [17-2304, 17-2305, 17-2306] [LMS] [Entered: 01/31/2019 11:58 AM] (3) |
| Jan 25, 2019 | 80 | MOTION of Appellee Coherus BioSciences Inc. to withdraw party, Coherus Biosciences, Inc., as a party to this appeal [Consent: unopposed]. Service: 01/25/2019 by email. [581137] [17-2304] [Craig Countryman] [Entered: 01/25/2019 04:20 PM] (5) |
| Jan 18, 2019 | 78 | ORDER filed. The motion [77] is granted. The deadline will be reset by future order of the court after the partial shutdown ends. Service: 01/18/2019 by clerk. [579399] [NL] [Entered: 01/18/2019 03:15 PM] (2) |
| Jan 16, 2019 | 77 | MOTION of Intervenor US to extend the time to a number of days commensurate with the lapse of appropriations for the U.S. Department of Justice to file the intervention brief. [Consent: unopposed]. Service: 01/16/2019 by email. [578405] [17-2304] [Dennis Fan] [Entered: 01/16/2019 09:17 AM] (5) |
| Jan 16, 2019 | 79 | Notice of Appointment of New Solicitor for the U.S. Patent and Trademark Office. Service: 01/22/2019 by clerk. [579573] [17-2257, 17-2304, 17-2323, 17-2593, 17-2621, 18-1047, 18-1048, 18-1070, 18-1105, 18-1163, 18-1302, 18-1311, 18-1368, 18-1385, 18-1438, 18-1443, 18-1485, 18-1489, 18-1659, 18-1768, 18-1772, 18-1876, 18-1883, 18-1901, 18-1925, 18-1933, 18-1944, 18-1968, 18-2000, 18-2031, 18-2032, 18-2069, 18-2082, 18-2106, 18-2170, 18-2236, 18-2271, 18-2329, 19-1049, 19-1117, 19-1334] [MJL] [Entered: 01/22/2019 10:12 AM] (1) |
| Jan 7, 2019 | 76 | ORDER filed. The motion [75] is granted to the extent that the time for the United States to file its brief is extended by fourteen days, to January 23, 2019, subject to renewal. Service: 01/07/2019 by clerk. [576281] [LMS] [Entered: 01/07/2019 12:14 PM] (2) |
| Dec 26, 2018 | 75 | MOTION of Intervenor US to extend the time to a number of days commensurate with the lapse of appropriations for the U.S. Department of Justice to file the Intervention Brief. [Consent: not addressed]. Service: 12/26/2018 by email. [574427] [17-2304] [Dennis Fan] [Entered: 12/26/2018 11:55 AM] (5) |
| Dec 6, 2018 | 72 | Entry of appearance for Joseph Matal as of counsel for Intervenor US. Service: 12/06/2018 by email. [569811] [17-2304] [Joseph Matal] [Entered: 12/06/2018 10:26 AM] (2) |
| Dec 6, 2018 | 73 | Entry of appearance for Thomas W. Krause as of counsel for Intervenor US. Service: 12/06/2018 by email. [569815] [17-2304] [Thomas Krause] [Entered: 12/06/2018 10:30 AM] (2) |
| Dec 6, 2018 | 74 | Entry of appearance for Farheena Y. Rasheed as of counsel for Intervenor US. Service: 12/06/2018 by email. [569818] [17-2304] [Farheena Rasheed] [Entered: 12/06/2018 10:33 AM] (2) |
| Dec 4, 2018 | 71 | ORDER filed. The motion [70] is granted. The revised official captions are reflected in the order. The stay is lifted. AbbVie Biotechnology, Ltd.'s reply brief is stricken. The United States's response brief is due no later than January 9, 2019. AbbVie's replacement reply brief is due no later than January 23, 2019. Service: 12/04/2018 by clerk. [569648] [LMS] [Entered: 12/04/2018 04:01 PM] (3) |
| Nov 30, 2018 | 70 | MOTION of United States for leave to intervene [Consent: unopposed]. Service: 11/30/2018 by email. [569045] [17-2304] [Dennis Fan] [Entered: 11/30/2018 05:01 PM] (4) |
| Nov 29, 2018 | 69 | Entry of appearance for Dennis Fan as principal counsel for United States. Service: 11/29/2018 by email. [568743] [17-2304] [Dennis Fan] [Entered: 11/29/2018 06:04 PM] (1) |
| Oct 31, 2018 | 68 | ORDER filed. The proceedings in the above-captioned appeals are stayed. Notice of AbbVie's constitutional challenge [65] is hereby certified to the Attorney General. No later than 30 days from the date of filing of this order, the Attorney General is directed to inform this court whether the United States intends to intervene in these appeals. (see order for further details) Service: 10/31/2018 by clerk. [561516] [LMS] [Entered: 10/31/2018 08:33 AM] (3) |
| Oct 24, 2018 | 67 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:party letter Docket No. [66], ERROR: Counsel did not attach a certificate of service. CORRECTION: Please be sure to attach a certificate of service to all future filings. [559845] [JAB] [Entered: 10/24/2018 08:39 AM] (0) |
| Oct 23, 2018 | 66 | Notice from Appellee Coherus BioSciences Inc. regarding conflicts with oral argument.. Service: 10/23/2018 by email. [559804] [17-2304] [Craig Countryman] [Entered: 10/23/2018 08:30 PM] (1) |
| Oct 17, 2018 | 65 | Notice from Appellant AbbVie Biotechnology, Ltd. Constitutional Challenge Pursuant To Fed. R. App. P. 44(a). Service: 10/17/2018 by email. [558151] [17-2304] [Thomas Saunders] [Entered: 10/17/2018 02:49 PM] (4) |
| Aug 10, 2018 | 63 | **TEXT ONLY** ORDER granting motion to withdraw attorney [62] Robert Manhas filed by Appellant AbbVie Biotechnology, Ltd.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [542107] [SJ] [Entered: 08/10/2018 02:00 PM] (0) |
| Aug 10, 2018 | 64 | Amended Certificate of Interest for the Appellant AbbVie Biotechnology, Ltd.. Service: 08/10/2018 by email. [542188] [17-2304] [Thomas Saunders] [Entered: 08/10/2018 03:54 PM] (3) |
| Aug 8, 2018 | 62 | MOTION of Appellant AbbVie Biotechnology, Ltd. to withdraw counsel Robbie Manhas [Consent: unopposed]. Service: 08/08/2018 by email. [541459] [17-2304] [Robert Manhas] [Entered: 08/08/2018 11:30 AM] (5) |
| May 21, 2018 | 61 | Notice from Appellee Coherus BioSciences Inc. regarding conflicts with oral argument (September 4-5, October 1, November 5 and December 3-7). Service: 05/21/2018 by email. [523397] [17-2304] [Jonathan Singer] [Entered: 05/21/2018 05:25 PM] (1) |
| May 16, 2018 | 60 | 6 paper copies of the Joint Appendix Brief [58] received from Appellant AbbVie Biotechnology, Ltd.. [522446] [CJF] [Entered: 05/17/2018 10:49 AM] (0) |
| May 14, 2018 | 59 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [July, August, September], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 05/21/2018. [521311] [CMP] [Entered: 05/14/2018 10:04 AM] (0) |
| May 11, 2018 | 57 | TENDERED from Appellant AbbVie Biotechnology, Ltd.. Title: JOINT APPENDIX. Service: 05/11/2018 by email. [521132] [17-2304] [Thomas Saunders] [Entered: 05/11/2018 03:15 PM] (1412) |
| May 11, 2018 | 58 | APPENDIX FILED for AbbVie Biotechnology, Ltd. [57]. Number of Pages: 1412. Service: 05/11/2018 by email. The paper copies of the brief should be received by the court on or before 05/21/2018. [521308] [CMP] [Entered: 05/14/2018 09:58 AM] (1412) |
| May 9, 2018 | 56 | 6 paper copies of the Reply Brief [55] received from Appellant AbbVie Biotechnology, Ltd. [520499] Stricken pursuant to the court's order. See Doc No. [71] [JCP] [Entered: 05/09/2018 04:41 PM] (0) |
| May 4, 2018 | 54 | TENDERED from Appellant AbbVie Biotechnology, Ltd.. Title: REPLY BRIEF. Service: 05/04/2018 by email. [519401] [17-2304] Stricken pursuant to the court's order. See Doc No. [71] [Thomas Saunders] [Entered: 05/04/2018 04:30 PM] (0) |
| May 4, 2018 | 55 | REPLY BRIEF FILED for Appellant AbbVie Biotechnology, Ltd. [54]. Number of Pages: 30. Service: 05/04/2018 by email. The paper copies of the brief should be received by the court on or before 05/15/2018. Appendix is due 05/11/2018. [519968] Stricken pursuant to the court's order. See Doc No. [71] [CMP] [Entered: 05/08/2018 11:23 AM] (0) |
| Mar 29, 2018 | 53 | 6 paper copies of the Opening Response Brief [49] received from Appellee Coherus BioSciences Inc. [509191] [SJL] [Entered: 03/29/2018 02:36 PM] (0) |
| Mar 28, 2018 | 52 | **TEXT ONLY** ORDER granting motion to extend time to file brief [50] filed by Appellant AbbVie Biotechnology, Ltd.. Reply brief is due 05/04/2018.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [508572] [CMP] [Entered: 03/28/2018 10:51 AM] (0) |
| Mar 27, 2018 | 51 | 8 paper copies of the Opening Response Brief [48] received from Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. [508357] [JCP] [Entered: 03/27/2018 03:37 PM] (0) |
| Mar 26, 2018 | 50 | MOTION of Appellant AbbVie Biotechnology, Ltd. to extend the time to 05/04/2018 to file the Reply Brief, currently due on April 6, 2018.. Any response is due within 10 days of service. [Consent: unopposed]. Service: 03/26/2018 by email. [507921] [17-2304] [Thomas Saunders] [Entered: 03/26/2018 02:16 PM] (8) |
| Mar 23, 2018 | 44 | Entry of appearance for Stephen B. Kinnaird as of counsel for Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Service: 03/23/2018 by email. [507407] [17-2304] [Stephen Kinnaird] [Entered: 03/23/2018 01:06 AM] (2) |
| Mar 23, 2018 | 45 | TENDERED from Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Title: RESPONSE BRIEF. Service: 03/23/2018 by email. [507709] [17-2304] [Eric Dittmann] [Entered: 03/23/2018 07:53 PM] (75) |
| Mar 23, 2018 | 46 | Entry of appearance for Jonathan E.Singer as of counsel for Appellee Coherus BioSciences Inc.. Service: 03/23/2018 by email. [507710] [17-2304] [Craig Countryman] [Entered: 03/23/2018 08:01 PM] (2) |
| Mar 23, 2018 | 47 | TENDERED from Appellee Coherus BioSciences Inc.. Title: RESPONSE BRIEF. Service: 03/23/2018 by email. [507711] [17-2304] [Craig Countryman] [Entered: 03/23/2018 08:03 PM] (65) |
| Mar 23, 2018 | 48 | BRIEF FILED for Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. [45]. Number of Pages: 60. Service: 03/23/2018 by email. The paper copies of the brief should be received by the court on or before 04/02/2018. [507817] [CMP] [Entered: 03/26/2018 11:06 AM] (75) |
| Mar 23, 2018 | 49 | BRIEF FILED for Appellee Coherus BioSciences Inc. [47]. Number of Pages: 54. Service: 03/23/2018 by email. The paper copies of the brief should be received by the court on or before 04/02/2018. Appellant AbbVie Biotechnology, Ltd. reply brief is due 04/06/2018. [507829] [CMP] [Entered: 03/26/2018 11:31 AM] (65) |
| Jan 16, 2018 | 43 | **TEXT ONLY** ORDER granting motion to extend time to file appellees' response brief [42] filed by Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. The brief is due 03/23/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [489620] [MJL] [Entered: 01/16/2018 10:24 AM] (0) |
| Jan 12, 2018 | 42 | MOTION of Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. to extend the time to 03/23/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/12/2018 by email. [489474] [Eric Dittmann] [Entered: 01/12/2018 04:59 PM] (12) |
| Jan 11, 2018 | 39 | CORRECTED ENTRY: MOTION of Appellee Coherus BioSciences Inc. to extend time until 03/23/2018 to file Appellee's Responsive Brief. [Consent: unopposed]. Service: 01/11/2018 by email. [489023]--[Edited 01/11/2018 by clerk to correct relief] [Craig Countryman] [Entered: 01/11/2018 02:04 PM] (9) |
| Jan 11, 2018 | 40 | Entry of appearance for Oliver J. Richards as of counsel for Appellee Coherus BioSciences Inc.. Service: 01/11/2018 by email. [489057] [Oliver Richards] [Entered: 01/11/2018 02:38 PM] (2) |
| Jan 11, 2018 | 41 | CORRECTED ENTRY: **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [39] filed by Appellee Coherus BioSciences Inc. Appellee Coherus BioSciences Inc.’s brief is due 03/23/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [489160] --[Edited 01/12/2018 by clerk to correct brief deadline] [CMP] [Entered: 01/11/2018 04:26 PM] (0) |
| Dec 19, 2017 | 38 | 6 paper copies of the Opening Brief [37] received from Appellant AbbVie Biotechnology, Ltd.. [484686] [JCP] [Entered: 12/21/2017 11:20 AM] (0) |
| Dec 13, 2017 | 35 | Entry of appearance for William F. Lee as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 12/13/2017 by email. [482440] [William Lee] [Entered: 12/13/2017 02:54 PM] (2) |
| Dec 13, 2017 | 36 | TENDERED from Appellant AbbVie Biotechnology, Ltd.. Title: OPENING BRIEF. Service: 12/13/2017 by email. [482510] [Thomas Saunders] [Entered: 12/13/2017 06:02 PM] (416) |
| Dec 13, 2017 | 37 | BRIEF FILED for Appellant AbbVie Biotechnology, Ltd. [36]. Number of Pages: 55. Service: 12/13/2017 by email. The paper copies of the brief should be received by the court on or before 12/22/2017. Appellees Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc. and Coherus BioSciences Inc. brief is due 01/22/2018. [483052] [CMP] [Entered: 12/15/2017 03:41 PM] (416) |
| Nov 13, 2017 | 34 | Amended Certificate of Interest for the Appellant AbbVie Biotechnology, Ltd.. Service: 11/13/2017 by email. [474850] [Thomas Saunders] [Entered: 11/13/2017 02:47 PM] (3) |
| Oct 26, 2017 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [32] filed by Appellant AbbVie Biotechnology, Ltd.. Brief is due 12/13/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [470784] [CMP] [Entered: 10/26/2017 12:00 PM] (0) |
| Oct 25, 2017 | 32 | MOTION of Appellant AbbVie Biotechnology, Ltd. to extend the time to 12/13/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/25/2017 by email. [470635] [Thomas Saunders] [Entered: 10/25/2017 05:26 PM] (8) |
| Sep 12, 2017 | 31 | Certified list from the United States Patent and Trademark Office. Service: 09/12/2017 by email. Appellant's brief is due 11/13/2017. [460603] [MJL] [Entered: 09/13/2017 10:32 AM] (267) |
| Aug 14, 2017 | 25 | Entry of appearance for Bruce M. Wexler as of counsel for Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Service: 08/14/2017 by email. [453898] [Bruce Wexler] [Entered: 08/14/2017 09:08 PM] (2) |
| Aug 14, 2017 | 26 | Entry of appearance for Isaac S. Ashkenazi as of counsel for Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Service: 08/14/2017 by email. [453899] [Isaac Ashkenazi] [Entered: 08/14/2017 09:14 PM] (2) |
| Aug 14, 2017 | 27 | Entry of appearance for Naveen Modi as of counsel for Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Service: 08/14/2017 by email. [453900] [Naveen Modi] [Entered: 08/14/2017 09:19 PM] (2) |
| Aug 14, 2017 | 28 | Entry of appearance for Eric W. Dittmann as principal counsel for Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Service: 08/14/2017 by email. [453902] [Eric Dittmann] [Entered: 08/14/2017 09:30 PM] (2) |
| Aug 14, 2017 | 29 | Certificate of Interest for the Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Service: 08/14/2017 by email. [453903] [Eric Dittmann] [Entered: 08/14/2017 09:33 PM] (3) |
| Aug 14, 2017 | 30 | Docketing Statement for the Appellees Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc.. Service: 08/14/2017 by email. [453904] [Eric Dittmann] [Entered: 08/14/2017 09:38 PM] (4) |
| Aug 4, 2017 | 22 | ORDER consolidating appeals in 17-2304, 17-2305, 17-2306, 17-2362, 17-2363. The certified lists are due no later than September 11, 2017. Service as of this date by Clerk of Court. [451628] [17-2304, 17-2305, 17-2306, 17-2362, 17-2363] [CMP] [Entered: 08/04/2017 03:36 PM] (2) |
| Aug 4, 2017 | 23 | Note to file: The following cases are associated: 17-2304 Lead with 17-2305, 17-2306, 17-2362, 17-2363 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [451634] [17-2304, 17-2305, 17-2306, 17-2362, 17-2363] [CMP] [Entered: 08/04/2017 03:55 PM] (0) |
| Aug 4, 2017 | 24 | Clerk's Note to the File: For Appellees Boehringer Ingelheim International GmBH and Boehringer Ingelheim Pharmaceuticals, Inc. the following deadlines have been set in case 17-2304: Entry of Appearance due 08/14/2017, Certificate of Interest is due on 08/14/2017, and Docketing Statement due 08/14/2017. [451638] [CMP] [Entered: 08/04/2017 04:04 PM] (0) |
| Jul 28, 2017 | 4 | Entry of appearance for Thomas G. Saunders as principal counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [449988] [Thomas Saunders] [Entered: 07/28/2017 01:05 PM] (2) |
| Jul 28, 2017 | 5 | Entry of appearance for Amy K. Wigmore as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [449991] [Amy Wigmore] [Entered: 07/28/2017 01:07 PM] (2) |
| Jul 28, 2017 | 6 | Entry of appearance for William G. McElwain as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [449996] [William McElwain] [Entered: 07/28/2017 01:09 PM] (2) |
| Jul 28, 2017 | 7 | Entry of appearance for Robbie Manhas as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [449999] [Robert Manhas] [Entered: 07/28/2017 01:12 PM] (2) |
| Jul 28, 2017 | 8 | Entry of appearance for David P. Yin as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [450003] [David Yin] [Entered: 07/28/2017 01:15 PM] (2) |
| Jul 28, 2017 | 9 | Certificate of Interest for the Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [450004] [Thomas Saunders] [Entered: 07/28/2017 01:17 PM] (2) |
| Jul 28, 2017 | 10 | Docketing Statement for the Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [450006] [Thomas Saunders] [Entered: 07/28/2017 01:18 PM] (4) |
| Jul 28, 2017 | 11 | Entry of appearance for Craig E. Countryman as of counsel for Appellee Coherus BioSciences Inc.. Service: 07/28/2017 by email. [450007] [Craig Countryman] [Entered: 07/28/2017 01:19 PM] (2) |
| Jul 28, 2017 | 12 | Entry of appearance for John Adkisson as of counsel for Appellee Coherus BioSciences Inc.. Service: 07/28/2017 by email. [450010] [John Adkisson] [Entered: 07/28/2017 01:22 PM] (2) |
| Jul 28, 2017 | 13 | Entry of appearance for Elizabeth M. Flanagan as of counsel for Appellee Coherus BioSciences Inc.. Service: 07/28/2017 by email. [450015] [Elizabeth Flanagan] [Entered: 07/28/2017 01:26 PM] (2) |
| Jul 28, 2017 | 14 | Entry of appearance for Michael J. Kane as of counsel for Appellee Coherus BioSciences Inc.. Service: 07/28/2017 by email. [450019] [Michael Kane] [Entered: 07/28/2017 01:29 PM] (2) |
| Jul 28, 2017 | 15 | Entry of appearance for W. Chad Shear as principal counsel for Appellee Coherus BioSciences Inc.. Service: 07/28/2017 by email. [450022] [W. Shear] [Entered: 07/28/2017 01:31 PM] (2) |
| Jul 28, 2017 | 16 | Docketing Statement for the Appellee Coherus BioSciences Inc.. Service: 07/28/2017 by email. [450023] [Craig Countryman] [Entered: 07/28/2017 01:34 PM] (3) |
| Jul 28, 2017 | 17 | Certificate of Interest for the Appellee Coherus BioSciences Inc.. Service: 07/28/2017 by email. [450024] [Craig Countryman] [Entered: 07/28/2017 01:35 PM] (2) |
| Jul 28, 2017 | 18 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The contact information on the entry of appearance for Elizabeth M. Flanagan [13] does not match the information in the attorney's user account. CORRECTION: Counsel should promptly update her contact information with the PACER Service Center. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [450061] [CMP] [Entered: 07/28/2017 02:25 PM] (0) |
| Jul 28, 2017 | 19 | Entry of appearance for William B. Raich as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [450128] [William Raich] [Entered: 07/28/2017 03:27 PM] (2) |
| Jul 28, 2017 | 20 | Entry of appearance for Charles E. Lipsey as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [450131] [William Raich] [Entered: 07/28/2017 03:28 PM] (2) |
| Jul 28, 2017 | 21 | Entry of appearance for Steven P. O'Connor as of counsel for Appellant AbbVie Biotechnology, Ltd.. Service: 07/28/2017 by email. [450134] [William Raich] [Entered: 07/28/2017 03:30 PM] (2) |
| Jul 17, 2017 | 2 | ORDER consolidating appeals (17-2304 Lead with 17-2305, 17-2306 Consolidated). Service as of this date by Clerk of Court. [446987] [17-2304, 17-2305, 17-2306] [CMP] [Entered: 07/17/2017 01:16 PM] (2) |
| Jul 17, 2017 | 3 | Note to file: The following cases are associated: 17-2304 Lead with 17-2305, 17-2306 Consoliated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [446991] [17-2304, 17-2305, 17-2306] [CMP] [Entered: 07/17/2017 01:21 PM] (0) |
| Jul 14, 2017 | 1 | Appeal docketed. Received: 07/14/2017. [446682] Entry of Appearance due 07/28/2017. Certificate of Interest is due on 07/28/2017. Docketing Statement due 07/28/2017. Certified List due on 08/23/2017. [CMP] [Entered: 07/14/2017 03:38 PM] (51) |
